Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Heavy charged particles for gastrointestinal cancers.
Isozaki Y, Takiyama H, Bhattacharyya T, Ebner D, Kasuya G, Makishima H, Tsuji H, Kamada T, Yamada S. Isozaki Y, et al. Among authors: kasuya g. J Gastrointest Oncol. 2020 Feb;11(1):203-211. doi: 10.21037/jgo.2019.03.14. J Gastrointest Oncol. 2020. PMID: 32175123 Free PMC article. Review.
Prospective clinical trial of 12-fraction carbon-ion radiotherapy for primary renal cell carcinoma.
Kasuya G, Tsuji H, Nomiya T, Makishima H, Haruyama Y, Kobashi G, Hayashi K, Ebner DK, Omatsu T, Kishimoto R, Yasuda S, Igarashi T, Oya M, Akakura K, Suzuki H, Ichikawa T, Shimazaki J, Kamada T; Working Group for Genitourinary Tumors. Kasuya G, et al. Oncotarget. 2019 Jan 1;10(1):76-81. doi: 10.18632/oncotarget.26539. eCollection 2019 Jan 1. Oncotarget. 2019. PMID: 30713604 Free PMC article.
Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study.
Mohamad O, Tabuchi T, Nitta Y, Nomoto A, Sato A, Kasuya G, Makishima H, Choy H, Yamada S, Morishima T, Tsuji H, Miyashiro I, Kamada T. Mohamad O, et al. Among authors: kasuya g. Lancet Oncol. 2019 May;20(5):674-685. doi: 10.1016/S1470-2045(18)30931-8. Epub 2019 Mar 15. Lancet Oncol. 2019. PMID: 30885458
Long-Term Results of High-Dose 2-Fraction Carbon Ion Radiation Therapy for Hepatocellular Carcinoma.
Yasuda S, Kato H, Imada H, Isozaki Y, Kasuya G, Makishima H, Tsuji H, Ebner DK, Yamada S, Kamada T, Tsujii H, Kato N, Miyazaki M; Working Group for Liver Tumor. Yasuda S, et al. Among authors: kasuya g. Adv Radiat Oncol. 2019 Sep 27;5(2):196-203. doi: 10.1016/j.adro.2019.09.007. eCollection 2020 Mar-Apr. Adv Radiat Oncol. 2019. PMID: 32280819 Free PMC article.
Significant impact of biochemical recurrence on overall mortality in patients with high-risk prostate cancer after carbon-ion radiotherapy combined with androgen deprivation therapy.
Kasuya G, Ishikawa H, Tsuji H, Nomiya T, Makishima H, Kamada T, Akakura K, Suzuki H, Shimazaki J, Haruyama Y, Kobashi G, Tsujii H; Working Group for Genitourinary Tumors. Kasuya G, et al. Cancer. 2016 Oct 15;122(20):3225-3231. doi: 10.1002/cncr.30050. Epub 2016 Jun 28. Cancer. 2016. PMID: 27351298 Free PMC article. Clinical Trial.
Cancer-specific mortality of high-risk prostate cancer after carbon-ion radiotherapy plus long-term androgen deprivation therapy.
Kasuya G, Ishikawa H, Tsuji H, Haruyama Y, Kobashi G, Ebner DK, Akakura K, Suzuki H, Ichikawa T, Shimazaki J, Makishima H, Nomiya T, Kamada T, Tsujii H; Working Group for Genitourinary Tumors. Kasuya G, et al. Cancer Sci. 2017 Dec;108(12):2422-2429. doi: 10.1111/cas.13402. Epub 2017 Nov 3. Cancer Sci. 2017. PMID: 28921785 Free PMC article.
Updated long-term outcomes after carbon-ion radiotherapy for primary renal cell carcinoma.
Kasuya G, Tsuji H, Nomiya T, Makishima H, Haruyama Y, Kobashi G, Ebner DK, Hayashi K, Omatsu T, Kishimoto R, Yasuda S, Igarashi T, Oya M, Akakura K, Suzuki H, Ichikawa T, Shimazaki J, Kamada T; Working Group for Genitourinary Tumors. Kasuya G, et al. Cancer Sci. 2018 Sep;109(9):2873-2880. doi: 10.1111/cas.13727. Epub 2018 Sep 1. Cancer Sci. 2018. PMID: 29981249 Free PMC article.
47 results